Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
1(8%)
Results Posted
20%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_4
1
8%
Ph phase_3
1
8%
Ph not_applicable
10
77%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (8.3%)
Phase 41 (8.3%)
N/A10 (83.3%)

Trials by Status

terminated18%
recruiting18%
unknown18%
completed1077%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13